Latest data on lecanemab presented at Alzheimer’s Association International Conference (AAIC)
BioArctic AB’s partner Eisai presented new data for lecanemab (BAN2401), an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of mild cognitive impairment (MCI) due ...